Stanley-Laman Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,023
| Closed | -$219K | – | 266 |
|
|
2019
Q2 | $219K | Buy |
+3,023
| New | +$219K | 0.05% | 263 |
|
|
2019
Q1 | – | Sell |
-2,875
| Closed | -$210K | – | 259 |
|
|
2018
Q4 | $210K | Buy |
+2,875
| New | +$210K | 0.06% | 238 |
|
|
2015
Q3 | – | Sell |
-3,000
| Closed | -$360K | – | 322 |
|
|
2015
Q2 | $360K | Hold |
3,000
| – | – | 0.07% | 235 |
|
|
2015
Q1 | $313K | Hold |
3,000
| – | – | 0.06% | 248 |
|
|
2014
Q4 | $291K | Hold |
3,000
| – | – | 0.06% | 265 |
|
|
2014
Q3 | $234K | Buy |
+3,000
| New | +$234K | 0.05% | 262 |
|
|
2014
Q2 | – | Sell |
-3,000
| Closed | -$201K | – | 291 |
|
|
2014
Q1 | $201K | Buy |
+3,000
| New | +$201K | 0.04% | 308 |
|